IMpower133 III期研究及IMbrella A 延伸研究中接受阿替利珠单抗治疗的广期小细胞肺癌患者五年生存率
Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension study
DOI 原文链接
用sci-hub下载
如无法下载，请从 Sci-Hub 选择可用站点尝试。
正在获取期刊数据...
发表日期:2024 Oct
作者:
DOI:10.1016/j.lungcan.2024.107924
摘要
AI正在翻译并加载中文摘要...